NCT07692789 Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems
| NCT ID | NCT07692789 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Pelvic Organ Prolapse |
| Study Type | INTERVENTIONAL |
| Enrollment | 162 participants |
| Start Date | 2026-08 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 162 participants in total. It began in 2026-08 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the impact of pre-procedure patient reminder systems on patient satisfaction, preparedness, and anxiety among patients undergoing urodynamics studies. The rate of successful procedure completion will be compared between a prospective intervention group and a historical control group to determine whether the intervention improves procedural success and healthcare delivery.
Eligibility Criteria
Inclusion Criteria 1. Age 18 years or older 2. Sex assigned at birth: Female. 3. English-speaking 4. Scheduled to undergo a urodynamics study at the OSU Upper Arlington Outpatient Clinic, OSU New Albany Outpatient Clinic, or OSU Eye and Ear Institute 5. Ability to access a telephone 6. Active MyChart account 7. Ability to provide informed consent 8. Documented post-residual volume of less than 150 mL 9. Ability to be reached by telephone after three call attempts 10. Negative point-of-care urinary tract infection on the day of the scheduled procedure (SOC) Exclusion criteria: 1. Under 18 years of age 2. Patients with structural causes of urinary retention/incomplete bladder emptying (defined as a post-void residual \>150ml) or a positive point-of-care urinary tract infection on the day of the procedure. 3. Men are excluded as the population of interest is the female urogynecology population in both urology and obstetrics and gynecology. 4. Patients without access to a telephone or an active MyChart account are excluded because the intervention relies on telephone calls and electronic messaging for delivery of pre-procedure education and reminders. 5. Individuals who cannot be reached by telephone are excluded because they cannot receive the intervention. 6. Non-English speaking individuals are excluded because they will not be able to receive the standardized phone call in English and will not be able to complete the informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07692789 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pelvic Organ Prolapse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07692789 currently recruiting?
Yes, NCT07692789 is actively recruiting participants. Contact the research team at Lisa.Hickman@osumc.edu for enrollment information.
Where is the NCT07692789 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT07692789 clinical trial?
NCT07692789 is sponsored by Ohio State University. The trial plans to enroll 162 participants.